Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Clinical Psychopharmacology

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JCP.0000000000000129PMID 24747979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

  2018cited by this paper
• Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

  2018cited by this paper
• Cannabidiol as potential anticancer drug

  2013cited by this paper
• Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses

  2013cited by this paper
• Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule‐1

  2012cited by this paper
• The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.

  2012cited by this paper
• The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.

  2012influential reference
• A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.

  2012cited by this paper
• Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

  2011cited by this paper
• Role of Cannabinoids in Multiple Sclerosis

  2011cited by this paper
• Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

  2011cited by this paper
• Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

  2010influential reference
• Cannabis-based medicines in multiple sclerosis--a review of clinical studies.

  2010cited by this paper
• Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

  2010cited by this paper
• Adverse health effects of non-medical cannabis use.

  2010cited by this paper
• Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

  2009influential reference
• Systematic review and meta-analysis of cannabis treatment for chronic pain.

  2009cited by this paper
• Cannabidiol: A Promising Drug for Neurodegenerative Disorders?

  2009cited by this paper
• Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside

  2009cited by this paper
• Cannabis and anxiety: a critical review of the evidence

  2009cited by this paper
• Adverse health effects of non-medical cannabis use.

  2009cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

  2008cited by this paper
• Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

  2007cited by this paper
• Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?

  2007cited by this paper
• Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

  2007cited by this paper
• Cannabidiolic‐acid synthase, the chemotype‐determining enzyme in the fiber‐type Cannabis sativa

  2007cited by this paper
• Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

  2007cited by this paper
• Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea.

  2007cited by this paper
• The association of consumer expectations, experiences and satisfaction with newly prescribed medications

  2007cited by this paper
• Cannabinoids in medicine: A review of their therapeutic potential.

  2006influential reference
• Cannabinoids and cancer: causation, remediation, and palliation.

  2005influential reference
• Limited use of medicinal cannabis but for labeled indications after legalization

  2005cited by this paper
• Medical use of cannabis in the Netherlands

  2005cited by this paper
• A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.

  2005cited by this paper
• Review of the validity and significance of cannabis withdrawal syndrome.

  2004cited by this paper
• Pharmacology of cannabinoids.

  2004cited by this paper
• Being stoned: a review of self-reported cannabis effects.

  2003cited by this paper
• The therapeutic potential of cannabis.

  2003cited by this paper
• The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature.

  2002cited by this paper
• Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans

  2002cited by this paper
• Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

  2002cited by this paper
• Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.

  2002cited by this paper
• Tetrahydrocannabinol and endocannabinoids in feeding and appetite.

  2002cited by this paper
• Therapeutic aspects of cannabis and cannabinoids

  2001cited by this paper
• Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

  2001cited by this paper
• Effects of Acute Smoked Marijuana on Complex Cognitive Performance

  2001cited by this paper
• Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report.

  2000cited by this paper
• Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques.

  1998cited by this paper
• Effects of Varying Marijuana Potency on Deposition of Tar and Δ9-THC in the Lung During Smoking

  1997cited by this paper
• Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking.

  1997cited by this paper
• Reliability, validity, and clinical application of the visual analogue mood scale

  1973cited by this paper

• Cannabis and sleep architecture: A systematic review and meta-analysis.

  2025cites this paper
• High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic Review.

  2025cites this paper
• High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies.

  2025cites this paper
• Contextual factors associated with subjective effects of cannabis: A systematic review and meta-analysis.

  2024cites this paper
• Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

  2023cites this paper
• Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany

  2023cites this paper
• Association of cannabis potency with mental ill health and addiction: a systematic review.

  2022cites this paper
• Policing Pot: State-Level Cannabis Arrests Increase Perceived Risks and Costs but Not Use

  2022cites this paper
• The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms

  2022cites this paper
• Impact of Cannabis Knowledge and Attitudes on Real-World Practice: An International Survey of Allergists.

  2022cites this paper
• Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

  2022cites this paper
• Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association.

  2022cites this paper
• Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care

  2022cites this paper
• Ten reasons to consider cannabinoids in everyday clinical practice

  2022cites this paper
• Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone

  2022cites this paper
• Cerebrovascular Effects of Alcohol Combined with Tetrahydrocannabinol

  2022cites this paper
• Cannabis Dosing and Administration for Sleep: A Systematic Review.

  2022cites this paper
• Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series

  2022cites this paper
• Cannabis and the Cancer Patient.

  2021cites this paper
• Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network.

  2021cites this paper
• Growing pains: An overview of cannabis quality control and quality assurance in Canada.

  2021cites this paper
• Prospects for the Use of Cannabinoids in Psychiatric Disorders

  2021cites this paper
• Current controversies in medical cannabis: recent developments in human clinical applications and potential therapeutics.

  2021cites this paper
• Specific Phytocannabinoid Compositions Are Associated With Analgesic Response and Adverse Effects in Chronic Pain Patients Treated with Medical Cannabis.

  2021cites this paper
• Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain.

  2021cites this paper
• Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person.

  2021cites this paper
• Medical Cannabis Use and Pain: An Experience Sampling Study

  2021cites this paper
• What are the experiences of patients using cannabis for pain? A systematic review of qualitative studies

  2021cites this paper
• Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions

  2020influential citation
• Mental Health and Cognition in Older Cannabis Users: a Review

  2020cites this paper
• Unintentional use of fentanyl attributed to surreptitious cannabis adulteration.

  2020cites this paper
• “The Good, the Bad, and the Ugly Weed”: How Consumers in Four Different Policy Settings Define the Quality of Illicit Cannabis

  2020cites this paper
• Possible therapeutic applications of cannabis in the neuropsychopharmacology field.

  2020cites this paper
• Marihuana: legalización y atención médica

  2019cites this paper
• Satisfaction with and factors related to medicinal herb consumption in older Iranian adults

  2019cites this paper
• Statistics Commentary Series: Commentary No. 31: The Uses and Misuses of the Analysis of Covariance.

  2019cites this paper
• What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes

  2019cites this paper
• Should Oncologists Recommend Cannabis?

  2019cites this paper
• Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes

  2019cites this paper
• Uso medicinal de cannabis: una revisión de la evidencia

  2019cites this paper
• Short- and Long-Term Effects of Cannabis on Headache and Migraine.

  2019cites this paper
• Chapter 82 – Palliative and End-of-Life Care

  2018cites this paper
• A Budding Cannabis Cottage-Industry has set the stage for an Impending Public Health Crisis

  2018cites this paper
• Cannabis in palliative care: current challenges and practical recommendations.

  2018cites this paper
• The association between physical pain and cannabis use in daily life: An experience sampling method.

  2018cites this paper
• The oncology nurse's role in patient education about the effects of marijuana on cancer palliation

  2018cites this paper
• Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents.

  2017cites this paper
• Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants

  2017cites this paper
• Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9- Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars

  2017cites this paper
• Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.

  2017cites this paper
• An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies

  2017influential citation
• Cannabinoid Therapeutics in Parkinson’s Disease: Promise and Paradox

  2017cites this paper
• Drug and non-drug reward processing in cigarette and cannabis users

  2016cites this paper
• Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?

  2016cites this paper
• Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses

  2016cites this paper
• Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: a qualitative study

  2015cites this paper
• Medicinal cannabis.

  2015cites this paper
• Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9‐tetrahydrocannabinol in Sprague‐Dawley rats

  2015influential citation
• Opioid prescribing pitfalls: medicolegal and regulatory issues.

  2015cites this paper
• Online pharmacies: buyer beware.

  2015cites this paper
• An Overview of Products and Bias in Research

  2015cites this paper
• A Summary of Selected Recent Research Concerning the Effects of Cannabis on Mental Health Conditions

  year unknowninfluential citation